Q1: What is Pharmaron known for in the life sciences industry?
Pharmaron is a leading global R&D service provider for the life sciences industry, offering integrated, end-to-end solutions to support the needs of its partners around the world. With a deep commitment to customer service and scientific excellence, Pharmaron has invested in its people, facilities and technology to develop a global end-to-end service platform for drug discovery, preclinical and clinical development, and commercialization across multiple therapeutic modalities, including small molecules, biologics, and CGT products. Pharmaron is known for its high-quality work coupled with flexibility and speed. Pharmaron is constantly strengthening its global service network to continue to play a leading role in the local and global life sciences industry, providing customised solutions and meeting its partners’ geographic and strategic needs.
Q2. As a company with a global presence, why would Pharmaron like to join the MVA?
The Nordic region is well-known for its rich ecosystem of innovative pharmaceutical and biotech companies, and academic institutions. Joining Medicon Valley Alliance (MVA) offers an opportunity for Pharmaron to connect with a thriving Scandinavian life sciences network, establishing new relationships and strengthening the region’s life sciences footprint. Additionally, joining MVA allows Pharmaron to share its passion for innovation in drug R&D and provides opportunities for Pharmaron to collaborate and share technologies, resources, experience, and knowledge with like-minded peers from across the industry. With five sites across the UK, Pharmaron is in close proximity to our clients and partners in this region, allowing us to better support their evolving needs and collaborate more closely with them to advance their pharmaceutical R&D programmes.
Q3: What inspires the Pharmaron team?
The Pharmaron team is inspired by the positive impact on our societies and people’s lives through their work. We share a deep sense of purpose and commitment to helping patients improve their quality of life and save lives by providing therapeutics in a timely, cost-effective and business-sustainable manner. It is in our DNA. With members from 27 countries across 21 sites in the UK, US and China, we foster a culture of innovation and collaboration, relentlessly pushing the boundaries of scientific innovation and excellence. The opportunity to work with cutting-edge technology and state-of-the-art facilities thanks to the company’s investment in the latest tools and technologies enables us to pursue our research with greater precision and efficiency. By working to create a more sustainable future, gives our teams a greater sense of purpose and fulfilment, knowing our efforts are making a difference for the better. It is our responsibility to explore new and more sustainable approachesto research and development, and we feel inspired when our contributions make the pharmaceutical industry more environmentally responsible. Examples of specific targets to track our progress towards this goal are our commitment to reducing our energy and water consumption, as well as CO2 emissions by 10% by 2025. Equally animal welfare is a significant concern in our field. Pharmaron’s ethical and responsible practices also inspire our teams to be more mindful of the impact of their work on the environment and other living beings. By considering the welfare of animals used in research, we have been working collectively to adopt and develop more sustainable practices. For example, we are developing new and more effective alternative methods that reduce or eliminate the need for animal testing.
Learn more about Pharmaron by visiting their website.